EyePoint Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release…

Biotechnology
US, Watertown [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of EYPT's Analysis
CIK: 1314102 CUSIP: 30233G209 ISIN: US30233G2093 LEI: - UEI: -
Secondary Listings
EYPT has no secondary listings inside our databases.